JP2022543112A5 - - Google Patents

Info

Publication number
JP2022543112A5
JP2022543112A5 JP2022506729A JP2022506729A JP2022543112A5 JP 2022543112 A5 JP2022543112 A5 JP 2022543112A5 JP 2022506729 A JP2022506729 A JP 2022506729A JP 2022506729 A JP2022506729 A JP 2022506729A JP 2022543112 A5 JP2022543112 A5 JP 2022543112A5
Authority
JP
Japan
Prior art keywords
cells
gene
sequence encoding
group
dux4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506729A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543112A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044635 external-priority patent/WO2021022223A1/en
Publication of JP2022543112A publication Critical patent/JP2022543112A/ja
Publication of JP2022543112A5 publication Critical patent/JP2022543112A5/ja
Pending legal-status Critical Current

Links

JP2022506729A 2019-08-01 2020-07-31 Ｄｕｘ４発現細胞およびそれらの使用 Pending JP2022543112A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881840P 2019-08-01 2019-08-01
US62/881,840 2019-08-01
PCT/US2020/044635 WO2021022223A1 (en) 2019-08-01 2020-07-31 Dux4 expressing cells and uses thereof

Publications (2)

Publication Number Publication Date
JP2022543112A JP2022543112A (ja) 2022-10-07
JP2022543112A5 true JP2022543112A5 (https=) 2023-08-08

Family

ID=72088403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506729A Pending JP2022543112A (ja) 2019-08-01 2020-07-31 Ｄｕｘ４発現細胞およびそれらの使用

Country Status (4)

Country Link
US (1) US20220267732A1 (https=)
EP (1) EP4007596A1 (https=)
JP (1) JP2022543112A (https=)
WO (1) WO2021022223A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11162079B2 (en) 2019-05-10 2021-11-02 The Regents Of The University Of California Blood type O Rh-hypo-immunogenic pluripotent cells
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
JP2024501971A (ja) 2020-12-31 2024-01-17 サナ バイオテクノロジー，インコーポレイテッド Ｃａｒ－ｔ活性を調節するための方法及び組成物
KR20240011831A (ko) * 2021-05-26 2024-01-26 후지필름 셀룰러 다이내믹스, 인코포레이티드 만능 줄기 세포에서 유전자의 신속한 사일런싱을 방지하기 위한 방법
WO2022269393A1 (en) * 2021-06-23 2022-12-29 Crispr Therapeutics Ag Engineered cells with improved protection from natural killer cell killing
KR20240046319A (ko) 2021-07-14 2024-04-08 사나 바이오테크놀로지, 인크. 저면역원성 세포에서의 y 염색체-연결 항원의 변경된 발현
AU2022327174A1 (en) 2021-08-11 2024-02-15 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells
EP4384598A1 (en) * 2021-08-11 2024-06-19 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
US20250339531A1 (en) * 2021-11-12 2025-11-06 Fred Hutchinson Cancer Center Dux4 polypeptides and nucleic acids for treating inflammatory and autoimmune conditions
CN119072319A (zh) 2021-12-23 2024-12-03 萨那生物技术股份有限公司 用于治疗自身免疫性疾病的嵌合抗原受体(car)t细胞及相关方法
US20250302953A1 (en) 2022-02-14 2025-10-02 Sana Biotechnology, Inc. Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
IL318041A (en) * 2022-07-01 2025-02-01 Janssen Biotech Inc Materials and methods for bioengineered iPSC populations
WO2024012420A1 (zh) * 2022-07-11 2024-01-18 士泽生物医药（苏州）有限公司 一种表达faslg的通用型细胞及其制备方法
WO2024125592A1 (zh) * 2022-12-16 2024-06-20 士泽生物医药（苏州）有限公司 一种通用型细胞及其制备方法
WO2025117331A1 (en) 2023-12-01 2025-06-05 Eli Lilly And Company Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same
WO2025230941A1 (en) 2024-04-30 2025-11-06 Satellite Biosciences, Inc. Hypoimmunogenic cell mixtures and methods of use thereof
WO2025230947A1 (en) 2024-04-30 2025-11-06 Satellite Biosciences, Inc. Engineered hepatocytes for secreting polypeptides
GB202415025D0 (en) * 2024-10-11 2024-11-27 Ospedale San Raffaele Srl Cell

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422251A (en) 1986-11-26 1995-06-06 Princeton University Triple-stranded nucleic acids
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5176996A (en) 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
DE19539493A1 (de) 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
AU776576B2 (en) 1999-12-06 2004-09-16 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6689558B2 (en) 2000-02-08 2004-02-10 Sangamo Biosciences, Inc. Cells for drug discovery
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
JP2005500061A (ja) 2001-08-20 2005-01-06 ザ スクリップス リサーチ インスティテュート Ｃｎｎについての亜鉛フィンガー結合ドメイン
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7253273B2 (en) 2004-04-08 2007-08-07 Sangamo Biosciences, Inc. Treatment of neuropathic pain with zinc finger proteins
AU2005232665B2 (en) 2004-04-08 2010-05-13 Sangamo Therapeutics, Inc. Methods and compositions for treating neuropathic and neurodegenerative conditions
ES2582091T3 (es) 2005-10-18 2016-09-09 Precision Biosciences Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
US9089520B2 (en) 2010-05-21 2015-07-28 Baylor College Of Medicine Methods for inducing selective apoptosis
CA3111953C (en) 2011-04-05 2023-10-24 Cellectis Method for the generation of compact tale-nucleases and uses thereof
WO2013130824A1 (en) 2012-02-29 2013-09-06 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
CN107921148A (zh) 2015-05-08 2018-04-17 哈佛学院校长同事会 通用供体干细胞和相关方法
WO2018073787A2 (en) * 2016-10-19 2018-04-26 Fred Hutchinson Cancer Research Center Compositions and methods for reprogramming cells and for somatic cell nuclear transfer using duxc expression
JP2020505025A (ja) 2017-01-13 2020-02-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫工学的な改変をした多能性細胞
CA3094322A1 (en) 2017-03-20 2018-09-27 Washington University Cells and methods of uses and making the same
WO2020028134A1 (en) * 2018-07-30 2020-02-06 Fred Hutchinson Cancer Research Center Methods and compositions for treating cancer

Similar Documents

Publication Publication Date Title
JP2022543112A5 (https=)
JP2022546317A5 (https=)
Kuhlmann et al. Chimeric antigen receptor T-cell approaches to HIV cure
Gornalusse et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
JP6516740B2 (ja) 幹細胞及びキメラ抗原受容体を介した抗腫瘍性ｔ細胞免疫の改変
Wu et al. Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies
US9228007B1 (en) Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells
CN115298314A (zh) 基因表达调控的安全开关
US20190161530A1 (en) Chimeric antigen receptor t cell compositions
US20230272429A1 (en) Modification of blood type antigens
HK1218232A1 (zh) 使用工程化鋅指蛋白核酸酶靶向斷裂t細胞受體基因
JP2025061188A (ja) キメラサイトカイン受容体
JP2022512674A (ja) 人工トランス活性化因子による選択
KR20210116531A (ko) 영양 장애형 표피 수포증 치료약
Zhang et al. Adoptive T cell therapy following haploidentical hematopoietic stem cell transplantation
Su et al. Genome-edited allogeneic CAR-T cells: the next generation of cancer immunotherapies
JP2025530328A (ja) 共発現ＴＧＦＢＲ ｓｈＲＮＡを有する免疫細胞
KR20230043906A (ko) 영양 장애형 표피 수포증의 치료약
Amrolia et al. Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation
CN111499766B (zh) 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用
JP7807756B2 (ja) 所望の特異性を有するエフェクター細胞の製造方法
US11903969B2 (en) Genome editing of graft-derived T-cells for post-transplant immunotherapy
KR102906951B1 (ko) 내인성 항원 제시 기전을 이용한 저면역원성 줄기세포 및 이의 제조 방법
Moen Transfection of Stem Cells and Gene Therapy
EA053040B1 (ru) Универсальная клетка и способ ее получения